COLGATE PALMOLIVE CO — Director's Dealing 2023

May 5, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLGATE PALMOLIVE CO (CL)
CIK: 0000021665
Period of Report: 2023-05-03

Reporting Person: Tsourapas Panagiotis (Grp Pres, Eur& Developing Mkts)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-05-03	Common Stock	M	35000.0000	$73.0000	Acquired	41906.0000	Direct
2023-05-03	Common Stock	S	35000.0000	$80.9356	Disposed	6906.0000	Direct
2023-05-04	Common Stock	M	20000.0000	$73.0000	Acquired	26906.0000	Direct
2023-05-04	Common Stock	S	20000.0000	$80.7799	Disposed	6906.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-05-03	Stock Option (Right to Buy)	$73.0000	M	35000.0000	Disposed	2023-09-25	Common Stock (35000.0000)	Direct
2023-05-04	Stock Option (Right to Buy)	$73.0000	M	20000.0000	Disposed	2023-09-25	Common Stock (20000.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4141.0000	Indirect
Common Stock	3226.0000	Indirect
Common Stock	59282.0000	Indirect

Footnotes

F1: Exercise of stock options awarded under the issuer's incentive compensation plan.

F2: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

F3: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.7388 to $81.1000, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $80.7700 to $80.8100, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: This amount includes 6,223 shares that were previously reported as directly beneficially owned.

F6: Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.